Who is sponsoring NCT03037957?

NCT03037957 is sponsored by Luminex Corporation.

What drugs are being tested in NCT03037957?

Interventions in NCT03037957: ARIES Group A Strep Assay.

What condition does NCT03037957 study?

NCT03037957 studies Pharyngitis Bacterial.

Is NCT03037957 still recruiting?

NCT03037957 is currently completed. Last updated 7 July 2017.

Last reviewed 2017-07-07 · How we verify

NCT03037957

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Multi-Site Clinical Evaluation of the ARIES Group A Strep Assay in Symptomatic Patients

Completed Last updated 7 July 2017

What this trial tests

trial testing ARIES Group A Strep Assay in Pharyngitis Bacterial in 704 participants. Completed in 2 June 2017.

Timeline

9 January 2017

Primary endpoint
2 June 2017

2 June 2017

Quick facts

Lead sponsor	Luminex Corporation
Status	Completed
Study type	OBSERVATIONAL
Enrollment	704
Start date	9 January 2017
Primary completion	2 June 2017
Estimated completion	2 June 2017
Sites	5 locations across United States

Drugs / interventions tested

ARIES Group A Strep Assay

Conditions studied

Pharyngitis Bacterial — all drugs for Pharyngitis Bacterial →

Sponsor

Luminex Corporation

Who can join

Eligibility, any sex, with Pharyngitis Bacterial. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A multi-center evaluation to assess the diagnostic sensitivity and specificity of the ARIES Group A Strep Assay will be established through a method comparison using prospectively collected, de-identified, clinical samples collected during the enrollment period.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03037957 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Luminex Corporation
Last refreshed: 7 July 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03037957.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing